The company’s executives will also attend the NASS meeting and will be available to answer questions about Bacterin’s spine product portfolio including OsteoSponge, OsteoSelect DBM Putty, OsteoWrap, OsteoSTX and the new 3Demin product line.
Bacterin focuses on developing, manufacturing and marketing biologic products to domestic and international markets.
More articles on devices:
Stryker hip implant settlement to exceed $1.4B—10 key facts
Orthopedic device market stock report—5 company updates
Alphatec Spine 3Q revenue up 2%: 10 key concepts
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
